Transfusion-associated Adverse Reactions (TAARs) and Cytokine Accumulations in the Stored Blood Components: the Impact of Prestorage Versus Poststorage Leukoreduction

Overview

Journal Oncotarget

Specialty Oncology

Date 2018 Feb 14

PMID 29435110

Citations 9

Authors

Chih-Chun Chang

Tai-Chen Lee

Ming-Jang Su

Hsiu-Chen Lin

Fang-Yi Cheng

Yi-Ting Chen

Tzung-Hai Yen

Fang-Yeh Chu

Affiliations

Soon will be listed here.

Abstract

Leukoreduction in blood units could prevent patients undergoing transfusions from transfusion-associated adverse reactions (TAARs) such as febrile nonhemolytic transfusion reactions (FNHTRs). However, the effect of prestorage and poststorage leukoreduction on TAARs and its underlying mechanisms in stored blood components remains to be determined. Therefore, we investigated the impact of prestorage leukocyte-reduced (pre-LR) and poststorage leukocyte-reduced (post-LR) blood products, including red blood cells (RBCs) and apheresis platelets (PHs), on the incidence of FNHTRs and other TAARs in patients who received transfusions from 2009 to 2014 in a tertiary care center. We also investigated the difference of leukocyte-related bioactive mediators between pre- and post-LR blood components. The results indicated that prevalence of TAARs was significantly reduced in the transfusions of pre-LR blood components. Particularly, the prevalence of FNHTRs was significantly reduced in the pre-LR RBC transfusions and the prevalence of allergy reactions was markedly reduced in the pre-LR PH transfusions. Furthermore, evaluation of cytokines in the pre- and post-LR blood components revealed that IL-1β, IL-8 and RANTES levels were significantly elevated in the post-LR RBCs during the storage. In contrast, IL-1β, IL-6 and IL-8 levels were significantly elevated in the post-LR PHs during the storage. These findings suggested that prestorage leukoreduction had a diminishing effect on the development of TAARs, which could be associated with less accumulation of cytokines in the stored blood components.

Citing Articles

Influence of the leukoreduction moment of blood components on the clinical outcomes of transfused patients in the emergency department.

Dejigov Monteiro da Silva N, Herbst A, Andre M, de Souza Nogueira L Rev Bras Enferm. 2024; 77(5):e20230293.

PMID: 39194129 PMC: 11346908. DOI: 10.1590/0034-7167-2023-0293.

Effect of post-storage filters vs. pre-storage filters for leukoreduction of blood components on clinical outcomes: a systematic review and meta-analysis.

Dejigov Monteiro da Silva N, Nukui Y, Takahashi J, Lopes Monteiro da Cruz D, de Souza Nogueira L Syst Rev. 2024; 13(1):196.

PMID: 39054473 PMC: 11270929. DOI: 10.1186/s13643-024-02615-z.

The platelet storage lesion, what are we working for?.

Liu C, Su Y, Guo W, Ma X, Qiao R J Clin Lab Anal. 2023; 38(1-2):e24994.

PMID: 38069592 PMC: 10829691. DOI: 10.1002/jcla.24994.

The use of premedications for platelet transfusions in pediatric patients.

Mccormick M, Triulzi D Hematology Am Soc Hematol Educ Program. 2020; 2020(1):523-526.

PMID: 33275693 PMC: 7727506. DOI: 10.1182/hematology.2020000165.

Platelet concentrate and type II IL-1 receptor are risk factors for allergic transfusion reactions in children.

Hu W, Feng L, Li M, Li T, Dai Y, Wang X Ital J Pediatr. 2020; 46(1):109.

PMID: 32727543 PMC: 7392823. DOI: 10.1186/s13052-020-00869-6.

References

Blumberg N, Heal J, Gettings K, Phipps R, Masel D, Refaai M . An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion. 2010; 50(12):2738-44. PMC: 2944002. DOI: 10.1111/j.1537-2995.2010.02748.x. View

Ferrer F, Rivera J, Corral J, Gonzalez-Conejero R, Vicente V . Evaluation of leukocyte-depleted platelet concentrates obtained by in-line filtration. Vox Sang. 2000; 78(4):235-41. DOI: 10.1159/000031187. View

Perrotta P, Snyder E . Non-infectious complications of transfusion therapy. Blood Rev. 2001; 15(2):69-83. DOI: 10.1054/blre.2001.0151. View

Bicalho B, Holovati J, Acker J . Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles. Biochim Biophys Acta. 2012; 1828(2):317-26. DOI: 10.1016/j.bbamem.2012.10.026. View

Hamzeh-Cognasse H, Damien P, Nguyen K, Arthaud C, Eyraud M, Chavarin P . Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions. Transfusion. 2013; 54(3):613-25. DOI: 10.1111/trf.12378. View

King K, Shirey R, Thoman S, Bensen-Kennedy D, Tanz W, Ness P . Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion. 2003; 44(1):25-9. DOI: 10.1046/j.0041-1132.2004.00609.x. View

Zhuang Y, Zhang T, Wei C, Pan J, Wang S, Zhang A . [Effect of leukoreduction on tumor-associated cytokine accumutation in supernatant of stored packed red cells and its effect on tumor cell proliferation in vitro]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015; 23(1):217-21. DOI: 10.7534/j.issn.1009-2137.2015.01.041. View

Bassuni W, Blajchman M, Al-Moshary M . Why implement universal leukoreduction?. Hematol Oncol Stem Cell Ther. 2010; 1(2):106-23. DOI: 10.1016/s1658-3876(08)50042-2. View

Block M, Nevala W, Leontovich A, Markovic S . Differential response of human and mouse dendritic cells to VEGF determines interspecies discrepancies in tumor-mediated TH1/TH2 polarity shift. Clin Cancer Res. 2011; 17(7):1776-83. DOI: 10.1158/1078-0432.CCR-10-2836. View

10.

Menitove J, McElligott M, Aster R . Febrile transfusion reaction: what blood component should be given next?. Vox Sang. 1982; 42(6):318-21. DOI: 10.1111/j.1423-0410.1982.tb01106.x. View

11.

Shanwell A, Kristiansson M, Remberger M, Ringden O . Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion. 1997; 37(7):678-84. DOI: 10.1046/j.1537-2995.1997.37797369441.x. View

12.

Singh S, Kumar A . Leukocyte depletion for safe blood transfusion. Biotechnol J. 2009; 4(8):1140-51. DOI: 10.1002/biot.200800182. View

13.

Cervia J, Wenz B, Ortolano G . Leukocyte reduction's role in the attenuation of infection risks among transfusion recipients. Clin Infect Dis. 2007; 45(8):1008-13. DOI: 10.1086/521896. View

14.

Tartter P, Mohandas K, Azar P, Endres J, Kaplan J, SPIVACK M . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg. 1999; 176(5):462-6. DOI: 10.1016/s0002-9610(98)00245-1. View

15.

Blumberg N, Zhao H, Wang H, Messing S, Heal J, Lyman G . The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Transfusion. 2007; 47(4):573-81. DOI: 10.1111/j.1537-2995.2007.01158.x. View

16.

Wadhwa M, Seghatchian M, Dilger P, Sands D, Krailadisiri P, Contreras M . Cytokines in WBC-reduced apheresis PCs during storage: a comparison of two WBC-reduction methods. Transfusion. 2000; 40(9):1118-26. DOI: 10.1046/j.1537-2995.2000.40091118.x. View

17.

Yazer M, Podlosky L, Clarke G, Nahirniak S . The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion. 2003; 44(1):10-5. DOI: 10.1046/j.0041-1132.2003.00518.x. View

18.

Lin J, Tzeng C, Hu H, Ho Y, Liu J, Ho C . Cytokine release in febrile non-haemolytic red cell transfusion reactions. Vox Sang. 2002; 82(3):156-60. DOI: 10.1046/j.1423-0410.2002.00159.x. View

19.

Rajesh K, Harsh S, Amarjit K . Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital. Ann Med Health Sci Res. 2015; 5(3):185-8. PMC: 4455008. DOI: 10.4103/2141-9248.157498. View

20.

Chen D, Wen Y, Lu J, Tseng C, Chen W, Chang S . Human platelet antigens are associated with febrile non-hemolytic transfusion reactions. Clin Chim Acta. 2017; 474:120-123. DOI: 10.1016/j.cca.2017.09.010. View